Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

MOR103 (PerC6 inside) PHASE I

181 Posts
Pagina: «« 1 ... 5 6 7 8 9 10 | Laatste | Omlaag ↓
  1. flosz 21 september 2012 11:34
    MorphoSys's MOR103 Antibody Demonstrates Excellent Safety and Efficacy in Rheumatoid Arthritis Patients
    www.morphosys.com/sites/default/files...

    MorphoSys to Host Conference Call on Clinical Trial Results of MOR103 in Rheumatoid Arthritis
    09/21/2012 - Conference Call and Webcast: Clinical Trial Results of MOR103 in Rheumatoid Arthritis
    Today at 3:00 p.m. CET (2:00 p.m. BST, 9:00 a.m. EDT), the Management Board of MorphoSys AG will host a public conference call and webcast to present information on the results of the clinical phase 1b/2a trial of MorphoSys's proprietary antibody MOR103 in patients with rheumatoid arthritis, which was announced yesterday.
    www.media-server.com/m/p/wbc89y57
181 Posts
Pagina: «« 1 ... 5 6 7 8 9 10 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 910,52 0,00%
EUR/USD 1,0826 +0,01%
FTSE 100 8.370,33 0,00%
Germany40^ 18.651,90 -0,15%
Gold spot 2.365,58 -0,54%
NY-Nasdaq Composite 16.801,54 -0,18%

Stijgers

AB InBev
0,00%
Ackerm...
0,00%
Aedifica
0,00%
Ageas
0,00%
Aperam
0,00%

Dalers

AB InBev
0,00%
Ackerm...
0,00%
Aedifica
0,00%
Ageas
0,00%
Aperam
0,00%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links